Cargando…

The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016

BACKGROUND: Pneumococcal disease is a major cause of morbidity and mortality worldwide, especially in patients with comorbidities and advanced age. This study evaluated trends in epidemiology of adult pneumococcal disease in Crete, Greece, by identifying serotype distribution and antimicrobial resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraki, Sofia, Mavromanolaki, Viktoria Eirini, Stafylaki, Dimitra, Hamilos, George, Samonis, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312900/
https://www.ncbi.nlm.nih.gov/pubmed/30600656
http://dx.doi.org/10.3947/ic.2018.50.4.328
_version_ 1783383846720372736
author Maraki, Sofia
Mavromanolaki, Viktoria Eirini
Stafylaki, Dimitra
Hamilos, George
Samonis, George
author_facet Maraki, Sofia
Mavromanolaki, Viktoria Eirini
Stafylaki, Dimitra
Hamilos, George
Samonis, George
author_sort Maraki, Sofia
collection PubMed
description BACKGROUND: Pneumococcal disease is a major cause of morbidity and mortality worldwide, especially in patients with comorbidities and advanced age. This study evaluated trends in epidemiology of adult pneumococcal disease in Crete, Greece, by identifying serotype distribution and antimicrobial resistance of consecutive Streptococcus pneumoniae strains isolated from adults during an 8-year time period (2009–2016) and the indirect effect of the infant pneumococcal higher-valent conjugate vaccines 10-valent pneumococcal conjugate vaccine (PCV10) and 13-valent pneumococcal conjugate vaccine (PCV13). MATERIALS AND METHODS: Antimicrobial susceptibility was performed by E-test and serotyping by Quellung reaction. Multidrug resistance (MDR) was defined as non-susceptibility to penicillin (PNSP) combined with resistance to ≥2 non-β-lactam antimicrobials. RESULTS: A total of 135 S. pneumoniae strains were isolated from adults during the study period. Twenty-one serotypes were identified with 17F, 15A, 3, 19A, and 11A, being the most common. The coverage rates of PCV10, and PCV13 were 17.8% and 37.8%, respectively. PCV13 serotypes decreased significantly from 68.4% in 2009 to 8.3% in 2016 (P = 0.002). The most important emerging non-PCV13 serotypes were 17F, 15A, and 11A, with 15A being strongly associated with antimicrobial resistance and MDR. Among all study isolates, penicillin-resistant and MDR strains represented 7.4% and 14.1%, respectively. Predominant PNSP serotypes were 19A (21.7%), 11A (17.4%), and 15A (17.4%). Erythromycin, clindamycin, tetracycline, trimethoprim-sulfamethoxazole, and levofloxacin resistant rates were 30.4%, 15.6%, 16.3%, 16.3%, and 1.5%, respectively. CONCLUSION: Although pneumococcal disease continues to be a health burden in adults in Crete, our study reveals a herd protection effect of the infant pneumococcal higher-valent conjugate vaccination. Surveillance of changes in serotype distribution and antimicrobial resistance among pneumococcal isolates are necessary to guide optimal prevention and treatment strategies.
format Online
Article
Text
id pubmed-6312900
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
record_format MEDLINE/PubMed
spelling pubmed-63129002019-01-07 The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016 Maraki, Sofia Mavromanolaki, Viktoria Eirini Stafylaki, Dimitra Hamilos, George Samonis, George Infect Chemother Original Article BACKGROUND: Pneumococcal disease is a major cause of morbidity and mortality worldwide, especially in patients with comorbidities and advanced age. This study evaluated trends in epidemiology of adult pneumococcal disease in Crete, Greece, by identifying serotype distribution and antimicrobial resistance of consecutive Streptococcus pneumoniae strains isolated from adults during an 8-year time period (2009–2016) and the indirect effect of the infant pneumococcal higher-valent conjugate vaccines 10-valent pneumococcal conjugate vaccine (PCV10) and 13-valent pneumococcal conjugate vaccine (PCV13). MATERIALS AND METHODS: Antimicrobial susceptibility was performed by E-test and serotyping by Quellung reaction. Multidrug resistance (MDR) was defined as non-susceptibility to penicillin (PNSP) combined with resistance to ≥2 non-β-lactam antimicrobials. RESULTS: A total of 135 S. pneumoniae strains were isolated from adults during the study period. Twenty-one serotypes were identified with 17F, 15A, 3, 19A, and 11A, being the most common. The coverage rates of PCV10, and PCV13 were 17.8% and 37.8%, respectively. PCV13 serotypes decreased significantly from 68.4% in 2009 to 8.3% in 2016 (P = 0.002). The most important emerging non-PCV13 serotypes were 17F, 15A, and 11A, with 15A being strongly associated with antimicrobial resistance and MDR. Among all study isolates, penicillin-resistant and MDR strains represented 7.4% and 14.1%, respectively. Predominant PNSP serotypes were 19A (21.7%), 11A (17.4%), and 15A (17.4%). Erythromycin, clindamycin, tetracycline, trimethoprim-sulfamethoxazole, and levofloxacin resistant rates were 30.4%, 15.6%, 16.3%, 16.3%, and 1.5%, respectively. CONCLUSION: Although pneumococcal disease continues to be a health burden in adults in Crete, our study reveals a herd protection effect of the infant pneumococcal higher-valent conjugate vaccination. Surveillance of changes in serotype distribution and antimicrobial resistance among pneumococcal isolates are necessary to guide optimal prevention and treatment strategies. The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2018-12 2018-12-14 /pmc/articles/PMC6312900/ /pubmed/30600656 http://dx.doi.org/10.3947/ic.2018.50.4.328 Text en Copyright © 2018 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Maraki, Sofia
Mavromanolaki, Viktoria Eirini
Stafylaki, Dimitra
Hamilos, George
Samonis, George
The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016
title The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016
title_full The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016
title_fullStr The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016
title_full_unstemmed The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016
title_short The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016
title_sort evolving epidemiology of serotype distribution and antimicrobial resistance of streptococcus pneumoniae strains isolated from adults in crete, greece, 2009–2016
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312900/
https://www.ncbi.nlm.nih.gov/pubmed/30600656
http://dx.doi.org/10.3947/ic.2018.50.4.328
work_keys_str_mv AT marakisofia theevolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT mavromanolakiviktoriaeirini theevolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT stafylakidimitra theevolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT hamilosgeorge theevolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT samonisgeorge theevolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT marakisofia evolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT mavromanolakiviktoriaeirini evolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT stafylakidimitra evolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT hamilosgeorge evolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016
AT samonisgeorge evolvingepidemiologyofserotypedistributionandantimicrobialresistanceofstreptococcuspneumoniaestrainsisolatedfromadultsincretegreece20092016